Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.52%

Cortex Pharmaceuticals, Inc. (CORX)

-Other OTC
0.03 Jul 10, 9:46AM EDT
|Pre-Market : NaN
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2011Dec 31, 2010Dec 31, 2009
Total Revenue 3,115   10,474   -  
Cost of Revenue -   -   -  
Gross Profit 3,115   10,474   -  
Operating Expenses
Research Development2,188  3,739  4,598  
Selling General and Administrative3,189  4,553  3,737  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (2,262) 2,182   (8,335)
Income from Continuing Operations
Total Other Income/Expenses Net -   -  (123)
Earnings Before Interest And Taxes(2,255)1,629  (8,441)
Interest Expense -   -   -  
Income Before Tax(2,255)1,629  (8,441)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(2,255)1,629  (8,441)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (2,255) 1,629   (8,441)
Preferred Stock And Other Adjustments -   -  (2,347)
Net Income Applicable To Common Shares (2,255) 1,629   (10,788)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.